Combining osteopathic manipulative medicine and phototherapy for chronic lower back pain relief
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
This study is testing if combining hands-on treatment and light therapy can help people with chronic lower back pain feel better than just using standard treatments or either method alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | New York Institute of Technology Academic / other |
| Locations | 1 site (Old Westbury, New York) |
| Trial ID | NCT01765777 on ClinicalTrials.gov |
What this trial studies
This research investigates whether the combination of osteopathic manipulative medicine (OMM) and phototherapy can provide greater pain relief for patients suffering from chronic lower back pain compared to standard medical management or either treatment alone. Previous studies have shown that both OMM and phototherapy are effective individually, but this study aims to explore their combined efficacy. Participants will be assessed for their chronic pain levels before and after treatment to evaluate the effectiveness of the combined approach.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 with chronic nonspecific lower back pain lasting at least three months.
Not a fit: Patients with specific underlying conditions such as ankylosing spondylitis, cancer, or those who have had recent lower back surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer enhanced pain relief for patients with chronic lower back pain.
How similar studies have performed: While both OMM and phototherapy have shown effectiveness individually, this combined approach is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age range: 18 - 65 years old * Subjects with constant or intermittent nonspecific lower back pain for a minimum of three (3) months duration. Exclusion Criteria: * Prospective subjects with a diagnosis of the following potential underlying causes of lower back pain: ankylosing spondylitis, cancer or a history of a histologically demonstrated malignant carcinoma, cauda equine syndrome, herniated disc, spinal fracture, or spinal osteomyelitis. * Prospective subjects who have undergone surgery of the lower back in the preceding three (3) months. * Prospective subjects who have received worker's compensation in the preceding three (3) months, or are involved in litigation involving concerns of lower back. * Prospective subjects who are pregnant. * Prospective subjects who have been a patient receiving any osteopathic manipulative medicine (OMM) treatment at the clinical trial site in the previous three (3) months, or on greater than three (3) occasions in the preceding year. * Prospective subjects who have ever been an employee at the clinical trial site. * Prospective subjects who have received spinal manipulation in the previous three (3) months, or on greater than three (3) occasions in the preceding year. * Prospective subjects who are currently involved in a physical therapy rehabilitation program. * Prospective subjects who have photosensitivity.
Where this trial is running
Old Westbury, New York
- New York Institute of Technology — Old Westbury, New York, United States (Recruiting)
Study contacts
- Principal investigator: Patricia S Kooyman, D.O. — New York Institute of Technology
- Study coordinator: Patricia S Kooyman, D.O.
- Email: pkooyman@nyit.edu
- Phone: 516-686-1309
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.